Elisa H F Jandrey
Overview
Explore the profile of Elisa H F Jandrey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
70
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chequin A, Costa L, de Campos F, Moncada A, de Lima L, Sledz L, et al.
Chem Biol Interact
. 2021 Sep;
349:109641.
PMID: 34534549
Breast cancer (BC) is the most frequently diagnosed female cancer and second leading cause of death. Despite the discovery of many antineoplastic drugs for BC, the current therapy is not...
2.
Jandrey E, Moura R, Andrade L, Machado C, Campesato L, Leite K, et al.
NPJ Breast Cancer
. 2019 Apr;
5:11.
PMID: 30963110
The risk of developing metastatic disease in breast cancer patients is traditionally predictable based on the number of positive axillary lymph nodes, complemented with additional clinicopathological factors. However, since lymph...
3.
Kiekow C, Figueiro F, Dietrich F, Vechia L, Pires E, Jandrey E, et al.
Eur J Pharm Sci
. 2016 Jan;
84:116-22.
PMID: 26802551
Treated glioblastoma multiforme (GBM) patients only survive 6 to 14months after diagnosis; therefore, the development of novel therapeutic strategies to treat gliomas remains critically necessary. Considering that phenolic compounds, like...
4.
Treptow T, Figueiro F, Jandrey E, Battastini A, Salbego C, Hoppe J, et al.
Eur J Med Chem
. 2015 Apr;
95:552-62.
PMID: 25863023
We described the first synthesis of fatty acid 3,4-dihydropyrimidinones (DHPM-fatty acids) using the Biginelli multicomponent reaction. Antiproliferative activity on two glioma cell lines (C6 rat and U-138-MG human) was also...
5.
Figueiro F, Bernardi A, Frozza R, Terroso T, Zanotto-Filho A, Jandrey E, et al.
J Biomed Nanotechnol
. 2013 Apr;
9(3):516-26.
PMID: 23621009
The development of novel therapeutic strategies to treat gliomas remains critical as a result of the poor prognoses, inef-. ficient therapies and recurrence associated with these tumors. In this context,...